Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation.
Leukemia
; 37(7): 1521-1529, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37316728
Full text:
1
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Multiple Myeloma
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article